ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

NEJM Paper Ignites Debate Over Spiral CT Scans For Lung Cancer.

November 3, 2006

Human Subject Rules Now Have forces Of Law; Already Conforming

June 7, 1974

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty

October 11, 2013

Cancer Care Act Introduced In Senate.

April 18, 2008